Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and Other Liabilities (Tables)

v3.21.1
Accrued expenses and Other Liabilities (Tables)
3 Months Ended
Mar. 31, 2021
Accrued expenses and Other Liabilities  
Schedule of accrued expenses and other liabilities

Accrued expenses and other liabilities consist of the following:

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

    

2021

    

2020

Accrued preclinical and clinical trial expenses

 

$

1,086,202

 

$

628,000

Accrued manufacturing expenses

 

 

15,000

 

 

175,089

Compensation and related benefits

 

 

225,095

 

 

209,600

Accrued franchise tax

 

 

55,000

 

 

172,500

Other expenses

 

 

383,088

 

 

429,345

 

 

$

1,764,385

 

$

1,614,534